Jim Cramer - Mad MoneyNovoCure LimitedNVCRDON'T BUYJan 29, 2025

He used to like this company a lot, but they fail to make money. Revenues are flat.

Jim Cramer - Mad Money

Unlock Rating

$25.52

Stock price when the opinion was issued

$17.49

As of Jun 16, 2026. Market Open.

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Wealthica Track your Stocks in your Watch List

You might be interested:

BUY

The medical community doesn't recognize this company, but when it does the stock will double.

BUY

Recommended this in early-2018. Why has it doubled recently? It works. A friend of his used NVCR medical machines, and his life was extended by three years.

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Jim Cramer - Mad MoneyNovoCure LimitedNVCRDON'T BUYJan 29, 2025

You might be interested:

NovoCure Limited(NVCR)

NovoCure Limited(NVCR)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals